版本:
中国

BRIEF-CRISPR Therapeutics announces European patent for CRISPR/Cas gene editing

March 28 Crispr Therapeutics AG:

* CRISPR Therapeutics announces European patent for CRISPR/Cas gene editing

* CRISPR Therapeutics - patent to include CRISPR/Cas9 gene editing compositions for use in any non-cellular and cellular setting Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐